Select Page

Toronto, Ontario–(Newsfile Corp. – September 26, 2019) – Alternate Health Corp. (CSE: AHG) (OTCQB: AHGIF) (“Alternate Health” or the “Company”), an international leader in CBD product development and distribution, announced today that the Company has launched a new wholesale CBD business line and signed a supply agreement targeting 1,000 kilograms of CBD per month.

“Like many pharmaceutical companies, we have been disappointed with the supply of quality CBD isolate and distillate available in the market, with very few shipments even matching the advanced Certificate of Analyses,” says Dr. Robert Blaine, President and Chief Medical Officer of Alternate Health at “We saw a huge gap in the market for quality wholesale CBD and we believe our decades of FDA-licensed drug manufacturing experience give us a unique advantage in addressing this challenge.”

Alternate CBD: Business Model

Alternate Health will base operations in its Blaine Labs campus in Santa Fe Springs, CA. As a licensed drug manufacturing facility, the Company believes this is the ideal venue to handle, package and stamp wholesale products. Alternate Health actively sources both raw hemp biomass and extracts, managing any additional processing, arranging strict testing, and carefully handles and packages products in our cGMP facility.

To meet initial estimated demand, Alternate Health has signed a supply agreement with Rising Sun Capital LLC, targeting the delivery of a combined 1,000 kilograms of hemp-derived CBD isolate and distillate per month. The Company will process, arrange testing and package CBD isolate, distillate and THC-Free Distillate. Alternate Health will arrange sales and distribution, having already secured interest from several potential buyers. For more information, visit .